eXmoor pharma secures £12m ($17m) from healthcare investment firm MVM marking milestone towards significant expansion plans
eXmoor, the expert cell and gene therapy (CGT) services company (Bristol, England), has announced an initial investment of £12m ($17m) from specialist healthcare investment firm MVM Partners (“MVM”), to enable eXmoor’s ambitious expansion plans.
